We examined whether ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester (SNJ-1945), a new orally available calpain inhibitor, might reduce retinal cell death in vivo and/or in vitro. Retinal cell damage was induced in vivo in mice by intravitreal injection of N-methyl-D-aspartate (NMDA), and SNJ-1945 was intraperitoneally or orally administered twice. NMDA-induced calpain activity (measured as the cleaved products of ␣-spectrin) and its substrate, p35 (a neuron-specific activator for cyclin-dependent kinase 5), in the retina were examined by immunoblotting. In RGC-5 (a rat retinal ganglion cell line) cell culture, cell damage was induced by a 4-h oxygenglucose deprivation (OGD) treatment followed by an 18-h reoxygenation period. In mouse retinas, SNJ-1945 (30 or 100 mg/kg i.p., 100 or 200 mg/kg p.o.) significantly inhibited the cell loss in the ganglion cell layer (GCL) and the thinning of the inner plexiform layer induced by NMDA. Furthermore, the number of positive cells for terminal deoxynucleotidyl transferase dUTP nick-end labeling was significantly reduced in the GCL and the inner nuclear layer of retinas treated with SNJ-1945 compared with vehicle-treated retinas 24 h after NMDA injection. Levels of cleaved ␣-spectrin products increased and p35 decreased 6 h after NMDA injection or later, and their effects were attenuated by SNJ-1945. In vitro, SNJ-1945 (10 and 100 M) inhibited the OGD stress-induced reduction in cell viability. In conclusion, SNJ-1945 may afford valuable neuroprotection against retinal diseases, because it was effective against retinal damage both in vitro and in vivo. Our results also indicate that calpain activation and subsequent p35 degradation may be involved in the mechanisms underlying retinal cell death.
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Retinal ganglion cell (RGC) death is a common feature of many ophthalmic disorders, including glaucoma, optic neuropathies, and various retinovascular diseases (diabetic retinopathy and retinal vein occlusions). Retinal ganglion cells are extremely sensitive to the effects of both glutamate and its analog N-methyl-D-aspartate (NMDA), both of which produce a dosedependent cell loss in vivo and in vitro. In addition, glutamate toxicity has been implicated in the pathophysiology of glaucoma (Dreyer, 1998) . Activation of Ca 2ϩ -permeable NMDA receptors and the subsequent neuronal Ca 2ϩ overloading have been shown to mediate glutamate-induced neuron death (Choi, 1994) . Induction of the Ca 2ϩ -activated neutral cysteine protease -calpain by micromolar concentrations of Ca 2ϩ occurs early in excitotoxic neuron death (Siman et al., 1989; Faddis et al., 1997) . Similar to the caspases, -calpain cleaves a variety of cytoskeletal proteins, enzymes, and transcription factors and could also interfere with the proteolytic activity of the caspases (Croall and DeMartino, 1991) .
The calpain family is represented by 15 genes in mammals and comprises two major isozymes (namely, -and m-calpain) , which have been well characterized (Saido et al., 1994; Evans and Turner, 2007) . These isozymes are expressed ubiquitously, and they differ primarily in their Ca 2ϩ requirement for half-maximal activation [3-50 M for -calpain (calpain-1) and 400 -800 M for m-calpain (calpain-2)] (Goll et al., 2003) . Calpain-mediated proteolysis has been observed in several pathological conditions, including Alzheimer's disease, Huntington's disease, and Parkinson's disease (Saito et al., 1993; Grynspan et al., 1997; Kim et al., 2001; Dufty et al., 2007) . Calpain is also apparently activated during the apoptosis of both PC12 cells (Ray et al., 2000) and cerebellar granule cells (Nath et al., 1996a) , as well as during the neuronal apoptosis induced by rat spinal cord injury (Ray et al., 1999) . Chiu et al. (2005) reported that, in rats, intravitreal injection of NMDA increases -calpain immunoreactivity in RGC layer cells and in the inner nuclear layer and that simultaneous injection of a calpain inhibitor reduces both cell death and the number of terminal deoxynucleotidyl transferase-mediated biotin-dUTP nick end labeling (TUNEL)-positive cells observed after an NMDA injection. Calpains share endogenous substrates (such as ␣-spectrin) with caspases, suggesting that they may play similar or overlapping roles in cell death, but the requirement for calpains in different forms of neuronal cell death is not well understood (Nath et al., 1996b) . The functional contributions made by calpains to neuronal cell death still require clarification.
A novel calpain inhibitor, SNJ-1945, has been shown to have good aqueous solubility, good plasma exposure, and good central nervous system penetration in both rats and monkeys (Oka et al., 2006b; Shirasaki et al., 2006) . Furthermore, the administration of SNJ-1945 at 100 mg/kg i.p. for 14 days produced no obvious toxicity signs or abnormalities in rats (Oka et al., 2006b ). To date, there have been no reports on the efficacy of this inhibitor against retinal ganglion cell damage. Therefore, the present study was designed to examine whether SNJ-1945 might inhibit the in vivo retinal neuronal death induced by NMDA in mice and/or the in vitro RGC-5 cell damage induced by ischemia-reoxygenation.
Materials and Methods
Materials. Dulbecco's modified Eagle's medium (DMEM) was purchased from Sigma-Aldrich (St. Louis, MO). SNJ-1945 was a gift from Senju Pharmaceutical Co. Ltd. (Kobe, Japan). Isoflurane was acquired from Nissan Kagaku (Tokyo, Japan), and fetal bovine serum (FBS) was obtained from Valeant Pharmaceuticals (Costa Mesa, CA).
In Vivo NMDA-Induced Retinal Damage. All experiments were performed in accordance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research and were approved and monitored by the Institutional Animal Care and Use Committee of Gifu Pharmaceutical University. Male adult ddY mice (closed colony albino mice) weighing 35 to 45 g (Japan SLC, Hamamatsu, Japan) were used for these experiments and were kept under controlled lighting conditions (12-h light:12-h dark). Anesthesia was induced using 3.0% isoflurane and maintained using 1.5% isoflurane in 70% N 2 O and 30% O 2 , delivered via an animal general anesthesia machine (Soft Lander; Sin-ei Industry Co. Ltd., Saitama, Japan). The body temperature was maintained between 37.0 and 37.5°C with the aid of a heating pad and heating lamp. Retinal damage was induced by injection (2 l/eye) of NMDA (Sigma-Aldrich) at 2.5 mM dissolved in 0.01 M phosphate-buffered saline (PBS). This was injected into the vitreous body of the left eye while mice were under the anesthesia described above. One drop of levofloxacin ophthalmic solution (Santen Pharmaceuticals Co. Ltd., Osaka, Japan) as an antibacterial solution was applied topically to the treated eye after the intravitreal injection. SNJ-1945 (10, 30 , or 100 mg/kg for i.p.; 100 or 200 mg/kg for p.o. by gavage) or an identical volume (10 ml/kg) of vehicle (0.5% sodium carboxymethyl cellulose) was administered at 30 min before and at 6 h after the NMDA injection.
Histological Analysis of Mouse Retina. Seven days after the NMDA injection, eyeballs were enucleated for histological analysis. The mice were euthanized with an overdose of sodium pentobarbital (80 mg/kg i.p. or a higher dose). Each eye was then enucleated and kept immersed for at least 24 h at 4°C in a fixative solution containing 4% paraformaldehyde. Six paraffin-embedded sections (thickness, 3 m), cut through the optic disc of each eye, were prepared using standard histological procedures and then stained with hematoxylin and eosin. Retinal damage was evaluated as described previously (Shimazawa et al., 2007) , with three sections from each eye used for the morphometric analysis. Light-microscope images were photographed, and the cell counts in the GCL at a distance between 350 and 650 m from the optic disc were measured on the photographs in a masked fashion by a single observer (S.S.). Data from three sections (selected randomly from the six sections) were averaged for each eye, and the values obtained were used to evaluate the cell count in the GCL.
TUNEL Staining. TUNEL staining was performed according to the manufacturer's protocols (in situ cell death detection kit; Roche Diagnostics, Mannheim, Germany) to determine the extent of retinal cell death induced by NMDA. The mice were euthanized with deep anesthesia 24 h after intravitreous injection of NMDA at 5 nmol/eye. The eyes were enucleated, fixed overnight in 4% paraformaldehyde, and immersed for 48 h in 25% sucrose with PBS. The eyes were then embedded in a supporting medium for frozen-tissue specimens (Tissue-Tek OCT compound; Sakura Finetek, Torrance, CA). Retinal sections were cut at 10-m thick on a cryostat at Ϫ25°C and stored at Ϫ80°C until staining. After being washed twice with PBS, sections were incubated with terminal deoxyribonucleotidyl transferase enzyme at 37°C for 1 h. After washing three times with PBS, fluorescence images were photographed, and the labeled cell counts in the GCL and inner nuclear layer (INL) at a distance between 375 and 625 m from the optic disc were obtained for two areas of the retina. The number of TUNEL-positive cells was averaged for these two areas, and the value was plotted as the number of TUNEL-positive cells in GCL and INL, respectively.
Immunoblotting. Retinas were lysed using a cell-lysis buffer [radioimmunoprecipitation assay buffer with protease and phosphatase inhibitor cocktails (Sigma-Aldrich), and 1 mM EDTA]. Lysates were solubilized in sodium dodecyl sulfate sample buffer, separated on 4 to 20% sodium dodecyl sulfate-polyacrylamide gradient gels, and transferred to polyvinylidene difluoride membrane (Immobilon-P; Millipore Corporation, Billerica, MA). Transfers were blocked for 1 h at room temperature with 5% Blocking One-P (Nakarai Tesque, Inc., Kyoto, Japan) in 10 mM Tris-buffered saline with 0.05% Tween 20 and then incubated overnight at 4°C with the primary antibody. The transfers were then rinsed with Tris-buffered saline with 0.05% Tween 20 and incubated for 1 h at room temperature in horseradish peroxidase goat anti-rabbit or goat anti-mouse (Pierce Endogen, Rockford, IL) diluted 1:2000. The immunoblots were developed using chemiluminescence (Super Signal West Femto Maximum Sensitivity Substrate; Pierce Endogen) and visualized with the aid of a digital imaging system (FAS-1000; Toyobo Co. Ltd., Osaka, Japan). The primary antibodies used were as follows: mouse anti-␣-spectrin (clone AA6; Millipore Corporation), rabbit anti-p35 (clone C64B10; Cell Signaling Technology Inc., Danvers, MA), and mouse anti-␤-actin (Sigma-Aldrich).
Immunostainings. At various times after intravitreal injection of NMDA, eyes were processed as in the TUNEL staining and finally prepared as 10-m-thick cryostat sections. Subsequently, the sec-
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jpet.aspetjournals.org tions were processed for immunofluorescent staining using a rabbit monoclonal antibody against p35 (1:200 dilution; Cell Signaling Technology Inc.). After incubation of the primary antibody for 2 h at 37°C, the sections were incubated with Alexa Fluor 488-conjugated secondary antibody (1:8000 dilution; Invitrogen, Carlsbad, CA) for 30 min at 37°C, mounted with a coverslip, and observed under an epifluorescence microscope (Power BX50; Olympus, Tokyo, Japan).
RGC-5 Culture. Cultures of RGC-5 were maintained in DMEM (low glucose; 1 mg/ml) supplemented with 10% FBS, 100 U/ml penicillin (Meiji Seika Kaisha Ltd., Tokyo, Japan), and 100 g/ml streptomycin (Meiji Seika Kaisha Ltd.) in a humidified atmosphere of 95% air and 5% CO 2 at 37°C. The RGC-5 cells were passaged by trypsinization every 3 days, as described in a previous report (Krishnamoorthy et al., 2001) .
Oxygen-Glucose Deprivation-Induced Cell Death in RGC-5 Cell Cultures. RGC-5 cells were plated at a density of 1000 cells/ well in 96-well culture plates (BD Biosciences, Franklin Lakes, NJ) with low-glucose DMEM with 10% FBS. Twenty-four hours later, to induce oxygen-glucose deprivation (OGD) stress, the cells were washed with DMEM without glucose and FBS and then placed in the same medium in a hypoxic incubator (94% N 2 , 5% CO 2 , and 1% O 2 ) for 4 h. At the end of the OGD period, glucose solution and FBS were added to give final concentrations of 4.5 mg/ml (high glucose) and 1%, respectively, and the cultures were put back in the incubator for an additional 18 h at the regular atmospheric oxygen level (reoxygenation). In the control group, the RGC-5 culture medium was replaced with DMEM with high glucose (4.5g/ml) and 1% FBS, and then the cells were placed in an aerobic-incubator (95% air, 5% CO 2 ) for 22 h. SNJ-1945 (10 and 100 M) or vehicle was added to the culture after the above replacement of the culture medium but immediately before the hypoxic treatment. Cell viability was measured at the end of the reoxygenation period. Cell viability was assessed after im-
with an electron carrier, 1-methoxy-5-methylphenazinium, methylsulfate (Cell Counting Kit-8; Dojin Kagaku, Kumamoto, Japan) for 3 h at 37°C, and absorbance was recorded at 450 nm (Jiang et al., 2004) . WST-8 was bioreduced by cellular dehydrogenases to an orange formazan product that is soluble in cell culture medium. The amount of formazan produced was directly proportional to the number of living cells. This absorbance was expressed as a percentage of that in control cells after subtraction of background absorbance.
Statistical Analysis. Data are presented as the mean Ϯ S.E.M. Statistical comparisons were made using a two-tailed Student's t test or Dunnett's test by means of STATVIEW version 5.0 (SAS Institute, Cary, NC). p Ͻ 0.05 was considered to indicate statistical significance.
Results

Effect of SNJ-1945 on Calpain Activation in Mouse
Retina after NMDA Injection. To examine calpain activation in the retina after intravitreal injection of NMDA, we measured the cleaved products (145/150 kDa) of ␣-spectrin, which is proteolyzed by activated calpain, using an immunoblotting procedure (Fig. 1, A and B) . As shown in Fig. 1A , intact ␣-spectrin (represented at 280 kDa) was observed in the vehicle-treated normal retina, whereas NMDA treatment resulted in the appearance of proteolysis products of ␣-spectrin. Quantitative analysis of band density showed significant increases of the cleaved product (at 150 kDa) of ␣-spectrin (proteolyzed by caspase-3 and calpain) and a new cleaved product (at 145 kDa) of ␣-spectrin (proteolyzed by calpain) at 6 and 12 h after NMDA injection. The levels of these products were reduced to control levels by 24 h after NMDA injection (Fig. 1B) . SNJ-1945 inhibited the increases of both of these two cleaved products (145/150 kDa) at 6 h after NMDA injection (Fig. 1C) , with its effect being significant at both doses of 30 and 100 mg/kg i.p. (Fig. 1D) .
Effects of SNJ-1945 Administered Intraperitoneally against NMDA-Induced Retinal Damage in Mice. Intravitreal injection of NMDA at 5 nmol per eye decreased both the cell count in the GCL and the thickness of the IPL in the retina (versus the nontreated normal retina) (Figs. 2, A, B , F, and G, and 3, A, B, E, and F). In the normal retina, the cell number in the GCL and the thickness of IPL were 107.0 Ϯ 3.8 cells/mm and 22.7 Ϯ 1.3 m, respectively (n ϭ 6). Intravitreal injection of NMDA significantly reduced the cell number in the GCL (to 38.4 Ϯ 2.2 cells/mm, n ϭ 8) and thickness of the IPL (to 11.5 Ϯ 0.7 m, n ϭ 8). Treatment with SNJ-1945 at 30 and 100 mg/kg i.p. significantly suppressed the decreases in GCL cell count and IPL thickness induced by NMDA (Fig. 2) .
Effects of SNJ-1945 Administered Orally against NMDA-induced Retinal Damage in Mice. Effects of SNJ-1945, when it was orally administered, on NMDA-induced retinal cell death were evaluated. Treatment with SNJ-1945 at 100 and 200 mg/kg p.o. suppressed the decreases in GCL cell count and IPL thickness induced by NMDA, with significant effects seen at 100 (GCL cell count only) and 200 mg/kg (GCL count and IPL thickness) doses (Fig. 3) .
NMDA-Induced Expression of TUNEL-Positive Cells. TUNEL-positive cells were observed in both GCL and the inner part of the INL at 24 h after NMDA injection (Fig. 4B) . In contrast, TUNEL-positive cells were almost absent from the untreated retinas (Fig. 4A) . SNJ-1945 (30 (Fig. 4, B to E) . In the present study, SNJ-1945 showed protective effects by both intraperitoneal and oral administrations on NMDA-induced retinal cell death. Therefore, the following studies used intraperitoneal administration of SNJ-1945 .
Effect of SNJ-1945 on p35 Degradation in Mouse Retina after NMDA Injection. Proteolytic cleavage of p35 by calpain produces p25 upon neurotoxic insult, resulting in prolonged activation and mislocalization of Cdk5 with p25. Accumulation of p25 is found in neurodegenerative diseases such as Alzheimer's disease (Patrick et al., 1999) . Therefore, we focused on the p35 changes after NMDA injection. Representative p35-immunofluorescence images in mouse retinal cross-sections at 6 and 24 h after NMDA injection are shown in Fig. 5 , A to C. In nontreated normal retinas, p35 protein was ubiquitously expressed (Fig. 5A) , and it was notably highly expressed along the endfeet of Mü llar cells and the outer plexiform layer. Furthermore, it was localized at cell periphery in cells of the GCL and INL but not in the jpet.aspetjournals.org outer nuclear layer. As shown in Fig. 5B , p35 fluorescence intensities in the GCL and the INL were reduced 6 h after NMDA injection, but no apparent changes were seen in the endfeet of Mü llar cells and the outer nuclear layer. By 24 h after injection, the localization in the GCL was apparently changed, because some of the cells in the GCL showed a condensed distribution (Fig. 5C ). As shown in Fig. 5D , p35 protein was detected as a 35-kDa single-band immunoblot from the vehicle-treated normal retinas. Intravitreal injection of NMDA significantly decreased p35 at 6 h, and this decrease persisted to the 24-h sampling time (Fig. 5E ). SNJ-1945 at 30 mg/kg i.p. significantly inhibited the decrease in the p35 at 6 h after NMDA injection (Fig. 5, F and G) .
Effect of SNJ-1945 on RGC-5 Cell Damage Induced in Vitro by OGD Stress. Calcium overload shares a common pathway for retinal cell death through NMDA-receptor activation and ischemia, and its increase in intracellular space can activate calpain. To examine the direct effect of SNJ-1945 against retinal cell death without affecting the pharmacokinetic profile of the test drug or blood flow, we examined the effect of SNJ-1945 on OGD-induced RGC-5 death, a mimic of an in vitro ischemia model. Representative fluorescence stainings of nuclei made using Hoechst 33342 dye are shown in Fig. 6 , A to C. Nontreated control cells displayed normal nuclear morphology (Fig. 6A) . OGD stress led to condensation and fragmentation of nuclei (Fig. 6B ), whereas treatment with SNJ-1945 at 10 M reduced the extent of these morphological changes (Fig. 6C ). In the cell-viability assay (performed using WST-8), OGD stress reduced cell viability by more than 50% (Fig. 6D) . SNJ-1945 at 10 and 100 M significantly inhibited this decrease in cell viability.
Discussion
In the present study, we demonstrated that systemic administration of SNJ-1945, a calpain inhibitor, reduced NMDA-induced retinal neuronal death in mice in vivo and OGD-induced RGC-5 cell damage in vitro.
Activation of the NMDA receptor leads to an intracellular Ca 2ϩ influx and, subsequently, to an activation of Ca 2ϩ -dependent enzymes (such as calpain) that may be detrimental to cell viability. Chiu et al. (2005) reported that -calpain, but not m-calpain, was increased in retinal extracts obtained 6 to 12 h after intravitreal injection of NMDA and that intensely immunopositive cells were colocalized with TUNEL-positive cells. Furthermore, retinal ischemia-reperfusion has been reported to increase the proteolysis of ␣-spectrin, a biochemical indicator of calpain activation, in the rat retina preceding induced retinal morphological damage (such as cell loss in GCL and IPL thinning). Furthermore, a calpain inhibitor, SJA6017, has been shown to protect against the cell loss in GCL seen after ischemia-reperfusion (Sakamoto et al., 2000) . In the present study, cleaved products of ␣-spectrin (represented as 145-and 150-kDa molecular mass proteins) were increased at 6 and 12 h after NMDA injection, and their increases were diminished at 24 h. Administration of the calpain inhibitor SNJ-1945, either orally or intraperitoneally, not only inhibited this production of cleaved ␣-spectrins but also caused an attenuation of the NMDA-induced retinal damage. These findings suggest that calpain activation may be involved in the retinal damage observed after NMDAreceptor activation or retinal ischemic insults. NMDA has been reported to induce apoptotic cell death in GCL and the (Lam et al., 1999) . In the GCL of mice, approximately 60% of the cells are displaced amacrine cells and the remaining cells are retinal ganglion cells, and amacrine cells are mostly located at the inner part of INL (Jeon et al., 1998) . In this study, NMDA also increased the number of TUNEL-positive cells in GCL and the inner part of the INL, and SNJ-1945 inhibited the increases in both regions. On the other hand, the cells in the GCL counted in hematoxylin and eosin staining include not only RGCs but also displaced amacrine cells. Although we did not determine the difference between RGCs and displaced amacrine cells in the protective effects of SNJ-1945 , SNJ-1945 protected against the presumed amacrine cell death in the inner part of INL. Accordingly, these findings suggest that SNJ-1945 can protect against cell death in RGCs and amacrine cells. However, further studies will be needed to provide direct evidence in GCL.
RGC death is a common feature of many ophthalmic disorders (such as glaucoma and central retinal artery or vein occlusion), and RGCs are susceptible to glutamate and ischemia. In previous studies on rat and primate retinal organotypic cultures, hypoxia (95% N 2 /5% CO 2 without glucose) induced activation of calpains and proteolysis of their substrates, and these effects could be inhibited by a calpainspecific inhibitor (SJA6017), resulting in a prevention of cell death (Tamada et al., 2002; Nakajima et al., 2006) . In the present study, RGC-5 cells clearly underwent cell death 24 h after oxygen-glucose deprivation (94% N 2 /1% O 2 /5% CO 2 ). Treatment with SNJ-1945 clearly protected against this cell death. As shown here, OGD stress induces RGC-5 cell death that is accompanied by nuclear condensation. This is the first study to demonstrate that a calpain inhibitor exerts a protective effect against OGD stress-induced RGC-5 cell death in vitro. We have recently observed that these effects could be abolished by chelation of extracellular Ca 2ϩ (using EDTA⅐Na) or by use of an inhibitor of the Na ϩ /Ca 2ϩ exchanger (Inokuchi et al., 2009 ). Furthermore, exposing RGC-5 cells in culture to ionomycin (a calcium ionophore) or interferon-␥ increases intracellular Ca 2ϩ influx, and calpeptin (a calpain-specific inhibitor) attenuates both proteolytic activities and apoptosis (Das et al., 2006) . These findings support the idea that calpain activation may be involved in the RGC cell death seen under hypoxic conditions. Activated calpain hydrolyzes a wide range of protein substrates including those involved in cytoskeletal structure (␣-spectrin, ␣-actinin, paxillin, etc.) . Cytoskeletal degradation in turn induces disruption of cellular architecture (Evans and Turner, 2007) . Furthermore, proteolysis by calpain can also degrade some apoptosis-related proteins, such as caspase-3 (Blomgren et al., 2001) , apoptosis-inducing factor (Polster et al., 2005) , and p35 (Lee et al., 2000) . Consequently, calpain can also be involved in the regulation of programmed cell SNJ-1945 . SNJ-1945 at 30 mg/kg i.p. or an identical volume (10 ml/kg) of vehicle (0.5% sodium carboxymethyl cellulose) was administered 30 min before intravitreal injection of NMDA (5 nmol/eye). G, quantitative analysis of the band density at 35 kDa. p35 reduction had the variability with a range of 50 to 80% reduction between each experiment (E and G). We used a semiquantitative analysis by Western blotting for comparing p35 level among samples; therefore, the variability may be due to the differences in transfer efficiency to blotting membranes and/or in some aspect of an animal's condition between each experiment. Each column represents the mean Ϯ S.E.M. (n ϭ 4 or 5). ##, p Ͻ 0.01 versus control; ‫,ء‬ p Ͻ 0.05 versus NMDA plus vehicle-treated group.
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at ASPET Journals on July 8, 2017 jpet.aspetjournals.org death. In our preliminary study, caspase-3 was hydrolyzed to a 30-kDa protein, a calpain-cleaved product, in mouse retinas at the early stages after intravitreal injection of NMDA. However, no apoptosis-inducing factor cleavage products were detected (M. Shimazawa and H. Hara, unpublished data) . On the other hand, significant effects were seen for p35 in response to NMDA injection. The p35 protein is a neuronspecific activator of cyclin-dependent kinase 5 (Cdk5), and its association with Cdk5 is critical for kinase activation. Cdk5 is a proline-directed serine/threonine kinase that is implicated in the regulation of neuronal migration, neuronal survival, and synaptic functions. Recently, Cdk5 has been reported to possibly exert a key role in promoting neuronal survival by regulating Akt activity through the neuregulin/ phosphatidylinositol 3-kinase signaling pathway and Bcl-2 activation, with phosphorylation by Cdk5 as the antiapoptotic effect (Cheung et al., 2008) . Proteolytic cleavage of p35 by calpain produces p25 upon neurotoxic insult, resulting in prolonged activation and mislocalization of Cdk5 with p25. Accumulation of p25 is found in neurodegenerative diseases such as Alzheimer's disease (Patrick et al., 1999) . Interestingly, subcellular localization of p35 is changed by proteolytic cleavage to p25; p35 is localized at the cell periphery bound for plasma membrane, and the p25 cleaved by calpain is enriched in nuclear and perinuclear regions of the cells (Patrick et al., 1999) . In the present study, p35 expressed in cells of GCL and INL in normal retina was predominantly localized at the cell periphery; however, p35 fluorescence was decreased at 6 h after NMDA treatment. Furthermore, 24 h after NMDA injection, p35 in some cells of the GCL showed smaller shape and condensed staining. Therefore, the alteration in subcellular localization with Cdk5 may promote its functional changes. On the other hand, the level of p35 was persistently decreased in mouse retinas after NMDA injection, and SNJ-1945 prevented the degradation of p35. However, the cleaved p25 protein was not detected in retinal extracts obtained from 6 to 24 h after NMDA injection in this study. Previously, Oka et al. (2006a) reported that transient ocular hypertension for 120 min and reperfusion induced a persistent decrease in p35 during 7 days and a transient increase in p25 at an early stage (4 h) after the ischemic insult, and its increase returned to a normal level by 12 h. Collectively, the immunofluorescence in retinal cross sections is considered to show p35, but not p25, at 6 and 24 h after NMDA injection. Furthermore, some condensed immunopositive cells in GCL at 24 h after NMDA are considered to result from morphological changes accompanied by cell death but not nuclear translocation of p25. These findings suggest that p35/Cdk5 may be critical for the maintenance of retinal cell survival and that p35 degradation induced by calpain activation may induce apoptotic cell death.
Overall, SNJ-1945 has good water solubility (0.65 mg/ml in water) (Shirasaki et al., 2006) , good penetration to blood and retina after oral administration (Shirasaki et al., 2005) , and a good safety profile (Oka et al., 2006b ). Moreover, systemically administered SNJ-1945 exerts protective effects against retinal damage (Oka et al., 2006b (Oka et al., , 2007 . This is the first study to demonstrate that a calpain inhibitor can, when given systemically, have protective effects against NMDA- induced mouse retinal damage in vivo. These findings indicate that SNJ-1945 may prove to be a useful candidate drug for neuroprotective interventions against retinal diseases. However, in the present study, we administered SNJ-1945 before NMDA injection. Therefore, further studies are needed to clarify its therapeutic time windows after NMDA injection.
In conclusion, we found that the calpain inhibitor SNJ-1945 protects against both NMDA-induced retinal damage and ischemia/reoxygenation-induced RGC-5 cell death. These findings suggest that calpain activation and subsequent p35 degradation may be involved in the mechanisms underlying the retinal cell death occurring in many ocular diseases.
